Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group P Karschnia, JS Young, A Dono, L Häni, T Sciortino, F Bruno, ST Juenger, ... Neuro-oncology 25 (5), 940-954, 2023 | 153 | 2023 |
Glioma and temozolomide induced alterations in gut microbiome A Patrizz, A Dono, S Zorofchian, G Hines, T Takayasu, N Husein, Y Otani, ... Scientific reports 10 (1), 21002, 2020 | 57 | 2020 |
Adult diffuse midline gliomas: clinical, radiological, and genetic characteristics A Dono, T Takayasu, LY Ballester, Y Esquenazi Journal of Clinical Neuroscience 82, 1-8, 2020 | 36 | 2020 |
Molecular characteristics and clinical features of multifocal glioblastoma A Dono, E Wang, V Lopez-Rivera, AV Ramesh, N Tandon, LY Ballester, ... Journal of neuro-oncology 148, 389-397, 2020 | 36 | 2020 |
PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma A Dono, S Mitra, M Shah, T Takayasu, JJ Zhu, N Tandon, CB Patel, ... Journal of neuro-oncology 153, 153-160, 2021 | 32 | 2021 |
IDH-mutant low-grade glioma: advances in molecular diagnosis, management, and future directions A Dono, LY Ballester, D Primdahl, Y Esquenazi, A Bhatia Current oncology reports 23, 1-12, 2021 | 32 | 2021 |
Glioma induced alterations in fecal short-chain fatty acids and neurotransmitters A Dono, A Patrizz, RM McCormack, N Putluri, BP Ganesh, B Kaur, ... CNS oncology 9 (2), CNS57, 2020 | 31 | 2020 |
Glioma and the gut–brain axis: opportunities and future perspectives A Dono, J Nickles, AG Rodriguez-Armendariz, BC McFarland, NJ Ajami, ... Neuro-oncology advances 4 (1), vdac054, 2022 | 24 | 2022 |
Differences in genomic alterations between brain metastases and primary tumors A Dono, T Takayasu, Y Yan, BE Bundrant, O Arevalo, CA Lopez-Garcia, ... Neurosurgery 88 (3), 592-602, 2021 | 24 | 2021 |
Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group P Karschnia, A Dono, JS Young, ST Juenger, N Teske, L Häni, T Sciortino, ... Neuro-oncology 25 (9), 1672-1685, 2023 | 22 | 2023 |
Cerebrospinal fluid ctDNA and metabolites are informative biomarkers for the evaluation of CNS germ cell tumors T Takayasu, M Shah, A Dono, Y Yan, R Borkar, N Putluri, JJ Zhu, S Hama, ... Scientific reports 10 (1), 14326, 2020 | 21 | 2020 |
Extent of resection and survival outcomes of geriatric patients with glioblastoma: is there benefit from aggressive surgery? V Lopez-Rivera, A Dono, CT Lewis, A Chandra, R Abdelkhaleq, SA Sheth, ... Clinical Neurology and Neurosurgery 202, 106474, 2021 | 18 | 2021 |
Landscape of Genomic Alterations in IDH Wild-Type Glioblastoma Identifies PI3K as a Favorable Prognostic Factor Y Yan, T Takayasu, G Hines, A Dono, SH Hsu, JJ Zhu, ... JCO Precision Oncology 4, 575-584, 2020 | 18 | 2020 |
The role of RB1 alteration and 4q12 amplification in IDH-WT glioblastoma A Dono, AV Ramesh, E Wang, M Shah, N Tandon, LY Ballester, ... Neuro-Oncology Advances 3 (1), vdab050, 2021 | 17 | 2021 |
IDH1 p. R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomas Y Fujita, L Nunez-Rubiano, A Dono, A Bellman, M Shah, JC Rodriguez, ... Journal of neuro-oncology 159 (2), 261-270, 2022 | 16 | 2022 |
Treatment trends and overall survival in patients with grade II/III ependymoma: The role of tumor grade and location V Lopez-Rivera, A Dono, R Abdelkhaleq, SA Sheth, PR Chen, A Chandra, ... Clinical Neurology and Neurosurgery 199, 106282, 2020 | 15 | 2020 |
Immunotyping of tumor-infiltrating lymphocytes in triple-negative breast cancer and genetic characterization GS Gomez-Macias, G Molinar-Flores, CA Lopez-Garcia, ... Oncology Letters 20 (5), 140, 2020 | 15 | 2020 |
Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group P Karschnia, J Dietrich, F Bruno, A Dono, ST Juenger, N Teske, JS Young, ... Neuro-oncology 26 (1), 166-177, 2024 | 13 | 2024 |
Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses A Dono, J Vu, M Anapolsky, G Hines, T Takayasu, Y Yan, N Tandon, ... Journal of neuro-oncology 149, 463-472, 2020 | 10 | 2020 |
Metastatic neoplasm volume kinetics following 2-stage stereotactic radiosurgery EP Damron, A Dono, H Chafi, M Martir, TK Yu, S Khwaja, M Amsbaugh, ... World Neurosurgery 161, e210-e219, 2022 | 9 | 2022 |